Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report

Creative Commons License

Vural S., Kuşdoğan M., Kaya H. B., İkiz V., Albayrak L.

Indian Journal of Otolaryngology and Head and Neck Surgery, cilt.75, sa.2, ss.1013-1015, 2023 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1007/s12070-022-03203-0
  • Dergi Adı: Indian Journal of Otolaryngology and Head and Neck Surgery
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.1013-1015
  • Anahtar Kelimeler: Anti-TNF, Adalimumab, Etanercept, Infliximab, Peritonsillar abscess, Deep infection
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Anti-tumor necrosis factor agents are widely used in treating ankylosing spondylitis, but they increase the risk of infection by suppressing the immune response. Therefore, physicians should be careful about recurrent infections in patients under anti-tumor necrosis factor agents.